Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Maren Schuhmann"'
Autor:
Amy Farr, Paul Clementsen, Felix Herth, Lars Konge, Rohde Gernot, Sarah Dowsland, Maren Schuhmann, Jouke Annema
Publikováno v:
Breathe, Vol 12, Iss 3, Pp 217-220 (2016)
Externí odkaz:
https://doaj.org/article/ee3b4f9b077c4389876dfaf17ba2a484
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 8 (2014)
Bronchial thermoplasty is a new treatment option for patients with severe bronchial asthma who remain symptomatic despite maximal medical therapy. The aim of this interventional therapy option is the reduction of smooth muscle in the central and peri
Externí odkaz:
https://doaj.org/article/2c4d43b38cde41b7a7c4f549dda03eb9
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 7 (2013)
Background: Central airway obstruction (CAO) is a life-threatening situation. Stent insertion re-establishes patency of the central airways. Self-expanding metallic Y stents have been available since 2005, widening the spectrum of interventional bron
Externí odkaz:
https://doaj.org/article/6467c52df84a4bb793e5ce829d3ddbbe
Autor:
Christian Taube, Tobias Welte, Benjamin Seeliger, Felix J.F. Herth, Karl-Christian Bergmann, Juergen Behr, Stephanie Korn, Nikolaus Kneidinger, Katrin Milger, Hendrik Suhling, Jan Fuge, Roland Buhl, Maren Schuhmann, Nora Drick, Benjamin Kendziora
Publikováno v:
Journal of Asthma and Allergy. 13:605-614
Background Anti-IL-5 antibodies represent an established therapy for severe eosinophilic asthma (SEA), but some patients show inadequate response. The objective of this study was to assess the effects of a switch to anti-IL-5Rα therapy in patients w
Autor:
Ralf Eberhardt, Daniela Gompelmann, Konstantina Kontogianni, Franz Stanzel, Felix J.F. Herth, Maren Schuhmann, Arschang Valipour, Vasiliki Gerovasili
Publikováno v:
Respiration. 99:333-343
Background: Endoscopic valve therapy aims at lung volume reduction that is associated with improved lung function, exercise tolerance and quality of life in emphysema patients. The size of intrabronchial valves of the Spiration® Valve System (SVS) s
Autor:
Sebastian Marwitz, January Weiner, Thierry Rolling, Victor Spinu, Dörte Nitschkowski, Florian P. Maurer, Marius Müller, Jan Heyckendorf, Anna M. Mandalakas, Jan Rybniker, Torsten Goldmann, Maja Reimann, Michael Hoelscher, Markus Unnewehr, Korkut Avsar, Helmut J. F. Salzer, Elmira Ibraim, Ioana D. Olaru, Andrea Rachow, Gunar Günther, Frank van Leth, Maren Schuhmann, Dagmar Schaub, Christoph Lange, Barbara Kalsdorf, Cristina Popa, Elena Terhalle, Patricia Sanchez-Carballo, Irina Kontsevaya, Isabelle Suárez, Stefan H. E. Kaufmann, Andrew R. DiNardo
Publikováno v:
European respiratory journal, 58(3):2003492. European Respiratory Society
Heyckendorf, Jan; Marwitz, Sebastian; Reimann, Maja; Avsar, Korkut; DiNardo, Andrew; Günther, Gunar; Hoelscher, Michael; Ibraim, Elmira; Kalsdorf, Barbara; Kaufmann, Stefan H E; Kontsevaya, Irina; van Leth, Frank; Mandalakas, Anna Maria; Maurer, Florian P; Müller, Marius; Nitschkowski, Dörte; Olaru, Ioana D; Popa, Cristina; Rachow, Andrea; Rolling, Thierry; ... (2021). Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. European respiratory journal, 58(3) European Respiratory Society 10.1183/13993003.03492-2020
European Respiratory Journal, 58(3):2003492, 1-13. European Respiratory Society
Heyckendorf, J, Marwitz, S, Reimann, M, Avsar, K, DiNardo, A R, Günther, G, Hoelscher, M, Ibraim, E, Kalsdorf, B, Kaufmann, S H E, Kontsevaya, I, van Leth, F, Mandalakas, A M, Maurer, F P, Müller, M, Nitschkowski, D, Olaru, I D, Popa, C, Rachow, A, Rolling, T, Rybniker, J, Salzer, H J F, Sanchez-Carballo, P, Schuhmann, M, Schaub, D, Spinu, V, Suárez, I, Terhalle, E, Unnewehr, M, Weiner, J, Goldmann, T & Lange, C 2021, ' Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model ', European Respiratory Journal, vol. 58, no. 3, 2003492, pp. 1-13 . https://doi.org/10.1183/13993003.03492-2020
Heyckendorf, Jan; Marwitz, Sebastian; Reimann, Maja; Avsar, Korkut; DiNardo, Andrew; Günther, Gunar; Hoelscher, Michael; Ibraim, Elmira; Kalsdorf, Barbara; Kaufmann, Stefan H E; Kontsevaya, Irina; van Leth, Frank; Mandalakas, Anna Maria; Maurer, Florian P; Müller, Marius; Nitschkowski, Dörte; Olaru, Ioana D; Popa, Cristina; Rachow, Andrea; Rolling, Thierry; ... (2021). Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. European respiratory journal, 58(3) European Respiratory Society 10.1183/13993003.03492-2020
European Respiratory Journal, 58(3):2003492, 1-13. European Respiratory Society
Heyckendorf, J, Marwitz, S, Reimann, M, Avsar, K, DiNardo, A R, Günther, G, Hoelscher, M, Ibraim, E, Kalsdorf, B, Kaufmann, S H E, Kontsevaya, I, van Leth, F, Mandalakas, A M, Maurer, F P, Müller, M, Nitschkowski, D, Olaru, I D, Popa, C, Rachow, A, Rolling, T, Rybniker, J, Salzer, H J F, Sanchez-Carballo, P, Schuhmann, M, Schaub, D, Spinu, V, Suárez, I, Terhalle, E, Unnewehr, M, Weiner, J, Goldmann, T & Lange, C 2021, ' Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model ', European Respiratory Journal, vol. 58, no. 3, 2003492, pp. 1-13 . https://doi.org/10.1183/13993003.03492-2020
BackgroundThe World Health Organization recommends standardised treatment durations for patients with tuberculosis (TB). We identified and validated a host-RNA signature as a biomarker for individualised therapy durations for patients with drug-susce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef72f5ef3406b43fadab06b729aeb5be
https://pure.amc.nl/en/publications/prediction-of-antituberculosis-treatment-duration-based-on-a-22gene-transcriptomic-model(4a364caf-28af-4e65-80f0-2ab79f922338).html
https://pure.amc.nl/en/publications/prediction-of-antituberculosis-treatment-duration-based-on-a-22gene-transcriptomic-model(4a364caf-28af-4e65-80f0-2ab79f922338).html
Autor:
Jan Heyckendorf, Maja Reimann, Sebastian Marwitz, Christoph Lange, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann
Publikováno v:
The Lancet Infectious Diseases, 21(8). Lancet Publishing Group
DZIF-TB cohort study group 2021, ' Pathogen-free diagnosis of tuberculosis ', The Lancet Infectious Diseases, vol. 21, no. 8, pp. 1066 . https://doi.org/10.1016/S1473-3099(21)00337-6
DZIF-TB cohort study group 2021, ' Pathogen-free diagnosis of tuberculosis ', The Lancet Infectious Diseases, vol. 21, no. 8, pp. 1066 . https://doi.org/10.1016/S1473-3099(21)00337-6
Autor:
Ralf Eberhardt, John Massie, Sarath Ranganathan, Louis Irving, Daniel P Steinfort, Felix J.F. Herth, Maren Schuhmann, Shivanthan Shanthikumar
Publikováno v:
Respiration. 98:340-346
Introduction: In adults, linear endobronchial ultrasound (EBUS) is the preferred modality to sample intrathoracic adenopathy and radial EBUS is a useful tool to biopsy peripheral pulmonary nodules. Utility in children is less well known. Objectives:
Autor:
Maria Vehresschild, Kathrin Tintelnot, Thomas Giese, Maren Schuhmann, Marija Stojkovic, Elvira Richter, Thomas Junghanss, Benjamin Egenlauf, Claus Peter Heussel, Felix J.F. Herth, Johann Greil, Michael Kreuter, Sybren de Hoog
Publikováno v:
Respiration. 97:472-475
GATA2 deficiency is characterized by monocytopenia, deficiency of dendritic cells, and a variable degree of lymphocytopenia affecting B cells and NK cells, leading to an enhanced risk of mycobacterial, viral, and fungal infections. Here we present a
Autor:
Helmut J. F. Salzer, Barbara Kalsdorf, Sebastian Marwitz, Victor Spinu, Frank van Leth, Michael Hoelscher, Elmira Ibraim, Andrea Rachow, Maren Schuhmann, Marius Müller, Jan Heyckendorf, Dörte Nitschkowski, Korkut Avsar, Irina Kontsevaya, Isabelle Suárez, Stefan H. E. Kaufmann, Christoph Lange, Andrew R. DiNardo, Patricia Sanchez-Carballo, Elena Terhalle, Ioana D. Olaru, Jan Rybniker, Cristina Popa, Gunar Günther, Florian P. Maurer, Dagmar Schaub, January Weiner, Thierry Rolling, Markus Unnewehr, Anna M. Mandalakas, Torsten Goldmann, Maja Reimann
Emerging multidrug-resistant tuberculosis is a major global health challenge. The World Health Organization currently recommends treatment durations of 9–18 months or more for patients with multidrug-resistant tuberculosis. We identified and valida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd7fd7aa56c60682229863be629c339
https://doi.org/10.1101/2020.08.21.20177238
https://doi.org/10.1101/2020.08.21.20177238